Tuesday, March 18, 2025
Home 2020

Yearly Archives: 2020

Hepion Pharma HEPA
Biotech News

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Editor / Curator -
Hapbee, EMulate, HAPB
Telehealth

A Medical Technology That Has The Highest Potential Over Any ...

Editor / Curator -
All News

OTC Markets Group Welcomes Direct Communication Solutions (DCSX), Inc. to OTCQX

Editor / Curator -
Drones

Alpine 4 Stock Surges After Impossible Aerospace Acquisition and DJI Blacklist

Editor / Curator -
Internet Stock Review
Stand Down.

Is The Market Overvalued? Barron’s Round Table January 2000.

Editor / Curator -
dexamethasone, Hepion
CoronaVirus

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung...

Editor / Curator -
Biotech News

Closing of $5.5 Million Public Offering.

Editor / Curator -
PetVivo, Biotech Stock Review
Biotech News

And Slowly But Surely..We Have Another 10-Bagger. PetVivo (PETV).

Editor / Curator -
Hapbee
Telehealth

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Editor / Curator -
HAPBEE
All News

Hapbee (HAPB): The Netflix of Feelings

Editor / Curator -
123...20Page 1 of 20

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.